
BALAXI PHARMACEUTICALS LIMITED has informed the Exchange about press release dated 23-May-2022 titled Balaxi Pharmaceuticals reports continued solid growth in Q4 and FY22���
Filed with NSE ·

BALAXI PHARMACEUTICALS LIMITED has informed the Exchange about press release dated 23-May-2022 titled Balaxi Pharmaceuticals reports continued solid growth in Q4 and FY22���
6ix hasn’t read this filing yet.
Balaxi Pharmaceuticals Limited on 6ix
Follow Balaxi Pharmaceuticals into a list and get an email when it puts out news.
Follow Balaxi Pharmaceuticals